United States· US:68180-286_e180b9ff-1e7c-422a-9fe7-afd39eee3e4e
ABACAVIR, LAMIVUDINE AND ZIDOVUDINE
A zidovudine, lamivudine and abacavir product containing lamivudine; zidovudine; abacavir sulfate, registered in United States by Lupin Pharmaceuticals, Inc.. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Zidovudine, lamivudine and abacavir is registered in 10 of 19 countries.
Countries holding a registration under ATC J05AR04 (zidovudine, lamivudine and abacavir), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Zidovudine, lamivudine and abacavir · ATC J05AR04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LAMIVUDINE; ZIDOVUDINE; ABACAVIR SULFATE
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- J05AR04
- ATC class
- Zidovudine, lamivudine and abacavir
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for zidovudine, lamivudine and abacavir.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zidovudine, lamivudine and abacavir · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Zidovudine, lamivudine and abacavir in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRIZIVIRViiV Healthcare BV, Amersfoort
- SpainTRIZIVIR 300 MG/150 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- FranceABACAVIR/LAMIVUDINE/ZIDOVUDINE VIATRIS 300 mg/150 mg/300 mg, comprimé pelliculéVIATRIS SANTE
- IrelandTrizivir 300 mg/150 mg/300 mg film-coated tabletsViiV Healthcare BV
- NetherlandsAbacavir/Lamivudine/Zidovudine Mylan 300 mg/150 mg/300 mg filmomhulde tablettenMylan Pharmaceuticals Limited
- FinlandTRIZIVIRViiV Healthcare BV
- IcelandTrizivirViiV Healthcare BV
- SwedenTRIZIVIR 300 mg/150 mg/300 mg Filmdragerad tablettViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- France · Abacavir/Lamivudine/Zidovudine Viatris
- Iceland · Trizivir
- Italy · Abacavir/Lamivudina/Zidovudina Mylan
- Liechtenstein · Trizivir
- Netherlands · Abacavir/Lamivudine/Zidovudine Mylan
- Norway · Trizivir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1d45a6cb-c745-4fbb-93cc-bc01b3cb32c3 GET /v1/drugs/1d45a6cb-c745-4fbb-93cc-bc01b3cb32c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "150; 300; 300",
"substance": "LAMIVUDINE; ZIDOVUDINE; ABACAVIR SULFATE",
"productndc": "68180-286",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1; mg/1",
"application_number": "ANDA202912",
"marketing_category": "ANDA"
}See everything about zidovudine, lamivudine and abacavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.